Tivic Health Systems, which makes a non-invasive neuromodulation device for sinus and nasal inflammation, raised $15 million by offering 3 million shares at $5, the low end of the range of $5 to $6. The company offered 0.3 million more shares than anticipated....read more
Tivic Health Systems, which makes a non-invasive neuromodulation device for sinus and nasal inflammation, announced terms for its IPO on Thursday. The Newark, CA-based company plans to raise $15 million by offering 2.7 million shares at a price range of $5 to...read more
After a busy July, the IPO market began to pump the brakes this past week with four IPOs and four postponements. SPAC activity remained steady with seven blank check IPOs. New filers trickled into the IPO pipeline, with only one IPO and six SPACs submitting...read more
Tivic Health Systems, which is commercializing a bioelectronic device for sinus and nasal inflammation, filed on Tuesday with the SEC to raise up to $16 million. Tivic is a commercial-phase bioelectronic medicine company focused on inflammation. Its first...read more
Nano-cap device maker Tivic Health Systems prices IPO at $5 low end
Tivic Health Systems, which makes a non-invasive neuromodulation device for sinus and nasal inflammation, raised $15 million by offering 3 million shares at $5, the low end of the range of $5 to $6. The company offered 0.3 million more shares than anticipated....read more
Inflammation-focused device maker Tivic Health Systems sets terms for $15 million IPO
Tivic Health Systems, which makes a non-invasive neuromodulation device for sinus and nasal inflammation, announced terms for its IPO on Thursday. The Newark, CA-based company plans to raise $15 million by offering 2.7 million shares at a price range of $5 to...read more
US IPO Weekly Recap: Postponements abound in a 4 IPO week
After a busy July, the IPO market began to pump the brakes this past week with four IPOs and four postponements. SPAC activity remained steady with seven blank check IPOs. New filers trickled into the IPO pipeline, with only one IPO and six SPACs submitting...read more
Inflammation-focused device maker Tivic Health Systems files for a $16 million IPO
Tivic Health Systems, which is commercializing a bioelectronic device for sinus and nasal inflammation, filed on Tuesday with the SEC to raise up to $16 million. Tivic is a commercial-phase bioelectronic medicine company focused on inflammation. Its first...read more